Update on Immunology of COVID-19 Disease and Potential Strategy for Controlling

Neda K Dezfuli1,2, Ian M Adcock3, Nooshin Montazami4

  • 1Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Tanaffos
|May 7, 2021
PubMed

Insights

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19, originating in bats and spreading globally. This review covers SARS-CoV-2 pathogenesis, clinical features, and potential treatments.

Area of Science:

  • Virology
  • Infectious Diseases
  • Public Health

Background:

  • Coronavirus disease 2019 (COVID-19) is a global pandemic caused by SARS-CoV-2, a novel beta-coronavirus.
  • The virus likely originated in bats, sharing genomic similarities with bat coronaviruses, and has spread to 261 countries.
  • SARS-CoV-2 utilizes the angiotensin-converting enzyme 2 (ACE2) receptor for cellular entry, primarily infecting the respiratory tract.

Purpose of the Study:

  • To review the pathogenesis of SARS-CoV-2 infection.
  • To describe the clinical characteristics of COVID-19 patients.
  • To discuss potential pharmacologic strategies for controlling COVID-19.

Main Methods:

  • Literature review of scientific articles on SARS-CoV-2 and COVID-19.
  • Analysis of epidemiological data on global spread.
  • Synthesis of information on viral mechanisms and clinical manifestations.

Main Results:

  • Common clinical symptoms include fever, cough, and fatigue; some patients experience gastrointestinal issues.
  • Older adults and individuals with metabolic or cardiovascular diseases face higher risks and worse outcomes.
  • Severe cases may involve acute respiratory distress syndrome (ARDS) and cytokine storm.

Conclusions:

  • Understanding SARS-CoV-2 pathogenesis and clinical presentation is crucial for effective management.
  • Targeting viral entry and host responses offers potential therapeutic avenues.
  • Continued research into pharmacologic approaches is vital for controlling the COVID-19 pandemic.

Related Concept Videos

Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.2K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
5.6K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
804
Controls in Experiments01:13

Controls in Experiments

When conducting an experiment, it is crucial to have control to reduce bias and accurately measure the dependent variables. It also marks the results more reliable. Controls are elements in an experiment that have the same characteristics as the treatment groups but are not affected by the independent variable. By sorting these data into control and experimental conditions, the relationship between the dependent and independent variables can be drawn. A randomized experiment always includes a...
14.3K
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
773
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
603